Arylsulfonamides From the Roots and Rhizomes of Tupistra chinensis Baker

Abstract

One new arylsulfonamide (1) and a novel natural product (2) were isolated from the roots and rhizomes of Tupistra chinensis Baker. Their structures were characterized by physicochemical properties and spectroscopic methods, as 2-[2-([1,1′-biphenyl]-4-ylsulfonylamino)-benzoylamino]-benzoic acid methyl ester (1), 2-[([1,1′-biphenyl]-4-ylsulfonyl)amino]-benzoic acid (2), respectively. Additionally, the cytotoxic activity of 1-2 was evaluated on human HCT116, HT29, A549, and H1299 tumor cell lines in vitro, respectively. Whereas, the result showed that these compounds displayed weak cytotoxicity in the human cancer cell lines.

Keywords

Arylsulfonamide Cytotoxicity

Tupistra chinensis Baker, a herbaceous perennial plant, is mostly distributed in China and India. It is a species in the Tupistra genus of Liliaceae family, which is medicinally known as “Kai-Kou-Jian” in the Qinba Mountains of Shaanxi Province in China,¹ and the roots and rhizomes are commonly used as one of the most important ingredients in many medical prescriptions for the treatment of throat irritation, rheumatic diseases, and snake-bite.² According to the results of modern pharmacological experiments, the extracts of this species possessed significant antitumor activity.^3,4

Previous investigations of bioactive constituents from the roots and rhizomes of T. chinensis by our research group had the presence of steroidal saponins.^5

-8 In order to explore more bioactive lead compounds from the medicinal herbs in the Qinba mountains of China,^9

-12 the chemical constituents and pharmacological studies of T. chinensis were studied, and 1 new arylsulfonamide 2-[2-([1,1′-biphenyl]-4-ylsulfonylamino)-benzoylamino]- benzoic acid methyl ester (1) (Figure 1) and an arylsulfonamide 2-[([1,1′-biphenyl]-4-ylsulfonyl)amino]-benzoic acid (2) firstly reported in plants. Natural products that contain sulfonamide groups in their structure were known, but they were rare.¹³ Sulfonamides acted on a range of molecular targets, including the α-carbonic anhydrase, which was a valid target for the development of novel antiglaucoma, antitumor, antiobesity, or anticonvulsant drugs.^14,15 In this article, we reported the isolation and structure elucidation of 2 sulfonamides and their cytotoxic evaluation against HCT116, HT29, A549, and H1299 tumor cells.

Figure 1

Chemical structure of the compounds 1-2.

Compound 1 was obtained as a white amorphous powder and soluble in chloroform. Its molecular formula was determined as C₂₇H₂₂N₂O₅S from the high-resolution electrospray ionization mass spectrometry (HR-ESI-MS) (Supplemental Figure S2) at m/z 485.1192 [M − H]⁻ (calcd for C₂₇H₂₁N₂O₅S, 485.1171). In the ¹H-nuclear magnetic resonance (NMR) spectrum (Supplemental Figure S3), 1 methyl proton signal was observed at δ _H 3.75 (3H, s, Me-23), 2 single peaks with nitrogenous proton signals at 11.7 (1H, s, N-H-b) and 10.46 (1H, s, N-H-a) in the low field region. In the aromatic region, 9 protons at δ _H 7.34 (1H, m, H-1), δ _H 7.33 (1H, m, H-2), δ _H 7.33 (1H, m, H-2′), δ _H 7.31 (1H, m, H-3), δ _H 7.31 (1H, m, H-3′), δ _H 7.45 (1H, d, J = 1.8 Hz, H-6), δ _H 7.43 (1H, d, J = 1.8 Hz, H-6′), δ _H 7.45 (1H, d, J = 1.8 Hz, H-7), and δ _H 7.43 (1H, d, J = 1.8 Hz, H-7′) suggesting the presence of a biphenylyl group, along with 8 aromatic protons at δ _H 7.77 (1H, dd, J = 1.0 Hz, J = 8.3 Hz, H-10), δ _H 7.51 (1H, m, H-11), δ _H 7.22 (1H, m, H-12), δ _H 7.30 (1H, dd, J = 1.0 Hz, J = 8.3 Hz, H-13), δ _H 8.73 (1H, dd, J = 1.6 Hz, J = 8.0 Hz, H-17), δ _H 7.61 (1H, m, H-18), δ _H 7.14 (1H, m, H-19), δ _H 7.95 (1H, dd, J = 1.6 Hz, J = 8.0 Hz, H-20) assigned to 2 bis-substituted benzene rings. The ¹³C-NMR (Supplemental Figure S4) and distortionless enhancement by polarization transfer spectrum (Table 1) of 1 displayed 27 carbon resonances, among them, 12 carbon resonances at δ _C 128.6 (C-1), 129.0 (C-2, C-2′), 127.2 (C-3, C-3′), 139.0 (C-4), 145.4 (C-5), 127.4 (C-6, C-6′), 128.0 (C-7, C-7′), and 137.7 (C-8) were attributed to a biphenylyl group. In the aromatic region, 2 benzene rings at δ _C 138.9 (C-9), 123.8 (C-10), 133.1 (C-11), 125.1 (C-12), 127.3 (C-13), 124.4 (C-14), and 141.2 (C-16), 120.5 (C-17), 135.1 (C-18), 123.5 (C-19), 131.3 (C-20), 115.4 (C-21). The above analysis was finally verified by the 2-dimensional (2D) NMR data. The heteronuclear multiple-quantum coherence (Supplemental Figure S5) experiment allowed for the assignments of the proton and protonated carbon resonances in the NMR spectra of 1. The heteronuclear multiple bond correlation (HMBC) (Supplemental Figure S6) of H-1/C-2 and C-3, H-3/C-1 and C-5, H-6/C-4, C-7 and C-8, H-11/C-9 and C-13, H-12/C-10 and C-14, H-13/C-9, C-11 and C-15, H-17/C-16, C-19 and C-21, H-20/C-16, C-18 and C-22, N-H-a/C-10. Among them, 2 carbonyl carbon signals at δ _C 167.2 (C-15) and 169.0 (C-22) showed correlations with proton signals of benzene moiety at δ _H 7.30 (H-13) and 7.95 (H-20), respectively. These results reveal that the 2 carbonyl carbons, respectively, connected with benzene rings. ¹H-¹H correlation spectroscopy (COSY) correlations (Supplemental Figure S7) of H-1/H-2/H-3, H-6/H-7, H-6′/H-7′, H-10/H-11/H-12/H-13, H-17/H-18/H-19/H-20; comparison with a known compound of NMR and HR-ESI-MS data of [2-(naphthalene-2-sulfonylamino)-benzoylamino]-benzoic acid methyl ester,¹⁶ showed that compound 1 had a similar structure, except the naphthalene group became the biphenyl group. In addition, the main fragmentation peaks of these 2 compounds were analyzed by HR-ESI-MS, and the following description indicates that the compound contains a sulfonamide bond. After correlation of all the protons with their directly bonded carbon partners via a heteronuclear single quantum coherence spectrum, it was possible from the HMBC and ¹H-¹H COSY spectrum (Figure 2) to deduce the planar structure of 1. Through a systematic literature search, compound 1 was found to be a new compound, and its structure was identified as 2-[2-([1,1′-biphenyl]-4-ylsulfonylamino)-benzoylamino]-benzoic acid methyl ester.

Figure 2

Key ¹H-¹H correlation spectroscopy (COSY) and heteronuclear multiple bond correlation (HMBC) relevant of compound 1

Table 1

¹H-NMR (400 MHz, CDCl₃) and ¹³C-NMR (100 MHz, CDCl₃) Data of Compound 1.

Position	δ _H	δ _C
1	7.34 (m)	128.6
2	7.33 (m)	129.0
2′	7.33 (m)	129.0
3	7.31 (m)	127.2
3′	7.31 (m)	127.2
4	-	139.0
5	-	145.4
6	7.45 (br s)	127.4
6′	7.43 (br s)	127.4
7	7.72 (br s)	128.0
7′	7.74 (br s)	128.0
8	-	137.7
9	-	138.9
10	7.77 (1H, dd, J = 1.0, J = 8.3)	123.8
11	7.51 (m)	133.1
12	7.22 (m)	125.1
13	7.30 (1 H, dd, J = 1.0, J = 8.3)	127.3
14	-	124.4
15	-	167.2
16	-	141.2
17	8.73 (1 H, dd, J = 1.6, J = 8.0)	120.5
18	7.61 (m)	135.1
19	7.14 (m)	123.5
20	7.95 (1 H, dd, J = 1.6, J = 8.0)	131.3
21	-	115.4
22	-	169.0
23	3.75 (br s)	52.6
NH-a	10.46 (br s)
NH-b	11.7 (br s)

CDCl₃, deuterated chloroform; NMR, nuclear magnetic resonance.

Compound 2 was obtained as a white amorphous powder and soluble in chloroform. Its molecular formula was determined as C₁₉H₁₅NO₄S. When comparing the ¹H-NMR and ¹³C-NMR data of 2 with the reported compound, 4-[([1,1'-biphenyl]-4-ylsulfonyl)amino]-benzoic acid,¹⁷ they showed almost the identical NMR features excepted for the location of the carboxyl. The only difference was that the para-position carboxyl unit became the ortho-position carboxyl unit. The structure of 2 was finally confirmed by the 2D-NMR as 2-[([1,1′-biphenyl]-4-ylsulfonyl)amino]-benzoic acid. Compound 2 is a novel natural product and the first time to report the spectrum data.

The compounds 1-2 were evaluated for their cytotoxic activity against HCT116, HT29, A549, and H1299 human cancer cell lines (Table 2). The compound 1 exhibited weak cytotoxicity against HT29 cell lines, with a half-maximal inhibitory concentration (IC₅₀) value of 89.3 µM. Compound 2 showed cytotoxicity against human cancer cell lines, HCT116 and H1299, with IC₅₀ values of 87.3 and 79.8 µM, respectively.

Table 2

Cytotoxicity of Compounds 1-2 Against 4 Human Cancer Cell Lines.

Compounds	Cell lines
Compounds	HCT116	HT29	A549	H1299
^b5-Fu	2.4 ± 1.9	4.3 ± 2.1	4.0 ± 1.6	3.07 ± 0.52
1	>100	89.3 ± 3.1	>100	>100
2	87.3 ± 2.6	>100	>100	79.8 ± 2.4

Experimental

General

ESI-MS was performed on Waters Quattro Premier instrument. The HR-ESI-MS spectra were taken on an Agilent Technologies 6550 Q-TOF. D and 2D NMR spectra were recorded on a Bruker-AVANCE 400 instrument with TMS as an internal standard. The analytical high-performance liquid chromatography (HPLC) was performed on a Waters 2695 Separations Module coupled with a 2996 Photodiode Array Detector and an Accurasil C18 column (4.6 mm × 250 mm, 5 mm particles, Ameritech, America). Semipreparative HPLC was performed on a system comprising an LC-6AD pump equipped with an SPD-20A UV detector and an Ultimate XB-C18 (10 mm × 250 mm, 5 mm particles). D101 was from Sunresin New Materials Co., Ltd. (Xi’an, China). Silica gel was purchased from Qingdao Haiyang Chemical Group Corporation (Qingdao, China).

Plant Material

The roots and rhizomes of T. chinensis Baker were collected from Taibai region of Qinba mountains in Shaanxi Province in September 2018 and identified by Senior experimentalist Jitao Wang. A voucher specimen (herbarium no. 20180916) has been deposited in the Medicinal Plants Herbarium (MPH), Shaanxi University of Chinese Medicine, Xianyang, China.

Extraction and Isolation

The air-dried and powdered underground parts of T. chinensis (1.5 kg) were extracted with 65% ethanol (EtOH) 3 times at 80°C. The combined EtOH extracts were evaporated to 5 L and applied to a resin D101 column, eluting with water (H₂O), 20% EtOH, 60% EtOH, and 95% EtOH to give 4 fractions (Fr.1-Fr.4). Fr.3 (45 g) was separated by silica gel column chromatography (CC), eluting with a gradient solvent system (chloroform [CHCl₃]–methanol [MeOH], 100:0-50:50) to yield 4 fractions (Fr.3-1-Fr.3-4). Fr.3-2 (20.3 g) was separated over silica gel using CHCl₃–MeOH (100:0-40:60) as eluent to obtain 5 fractions (Fr.3-2-1-Fr.3-2-5). Fr.3-2-2 (2.1 g) was recrystallized with CHCl₃–MeOH (1:1) to obtain compound 1 (30 mg). Fr.3-2-3 (8.3 g) was chromatographed repeatedly on silica gel elution with CHCl₃–MeOH (100:0-70:30) to afford 2 fractions (Fr.3-2-3-1 and Fr.3-2-3-2). Fr.3-2-3-1 (230 mg) was purified by HPLC (flow rate: 1.5 mL/min) with MeOH–H₂O (28:72) as the mobile phase, yielding compound 2 (10.6 mg; retention time [t_R] =41.5 minutes).

Cytotoxicity Assay

The cytotoxic activity assay toward the HCT116, HT29, A549, and H1299 tumor cell lines were measured by the 3-(4,5-dimethyl-thizol-2-yl)-2,5-diphenyltetrazolium bromide method in vitro, using 5-fluorouracil as a positive control. Briefly, 1 × 10⁴ mL cells were seeded into 96-well plates and allowed to adhere for 24 hours. Compounds 1-2 were dissolved in dimethyl sulfoxide (DMSO) and diluted with complete medium to 6 degrees of concentration (from 0.001 to 0.4 mmol/L) for inhibition rate determination. After incubation at 37°C for 4 hours, the supernatant fraction was removed before adding DMSO (100 µL) to each well. The inhibition rate and IC₅₀ were calculated (Table 2). Values are mean ± standard deviation, n = 3.

2-[2-([1,1′-Biphenyl]-4-Ylsulfonylamino)-Benzoylamino]-Benzoic Acid Methyl Ester (1)

White amorphous powder.

IR (potassium bromide [KBr]) ν _max: 3440, 2926, 2857, 1725, 1644, 1450, 1271, 1044, 845, 765 cm⁻¹.

¹H-NMR and ¹³C-NMR: Table 1.

HR-ESI-MS m/z 485.1192 [M − H]^- (calcd. for C₂₇H₂₁N₂O₅S, 485.1171).

2-[([1,1′-Biphenyl]-4-Ylsulfonyl)amino]-Benzoic Acid (2)

White amorphous powder.

IR (KBr) ν _max: 3438, 2932, 2844, 1716, 1622, 1455, 1298, 1025, 844, 767 cm⁻¹.

¹H-NMR (CDCl₃, 400 MHz): δ _H 7.38 (1H, m, H-1), δ _H 7.42 (1H, m, H-2), δ _H 7.42 (1H, m, H-2′), δ _H 7.59 (1H, m, H-3), δ _H 7.60 (1H, m, H-3′), δ _H 7.74 (1H, m, H-6), δ _H 7.73 (1H, m, H-6′), δ _H 8.11 (1H, t, J = 1.9 Hz, H-7), δ _H 8.09 (1H, t, J = 1.8 Hz, H-7′), δ _H 7.18 (1H, dd, J = 3.0 Hz, J = 5.8 Hz, H-10), δ _H 7.33 (1H, m, H-11), δ _H 7.33 (1H, m, H-12), δ _H 7.38 (1H, m, H-13). ¹³C-NMR (CDCl₃, 100 MHz): δ _C 129.1 (C-1), δ _C 129.3 (C-2), δ _C 129.3 (C-2′), δ _C 127.7 (C-3), δ _C 127.7 (C-3′), δ _C 139.4 (C-4), δ _C 147.5 (C-5), δ _C 127.9 (C-6), δ _C 127.9 (C-6′), δ _C 130.4 (C-7), δ _C 130.4 (C-7′), δ _C 136.3 (C-8), δ _C 134.5 (C-9), δ _C 129.4 (C-10), δ _C 132.2 (C-11), δ _C 130.8 (C-12), δ _C 128.9 (C-13), δ _C 133.7 (C-14), δ _C 165.7 (C-15).

Supplemental Material

Supplementary material - Supplemental material for Arylsulfonamides From the Roots and Rhizomes of Tupistra chinensis Baker

Supplemental material, Supplementary material, for Arylsulfonamides From the Roots and Rhizomes of Tupistra chinensis Baker by Yue Xu, Xiaofei Liang, Yuze Li, Zhuofei Liang, Wenli Huang, Huawei Zhang, Yi Jiang, Jiucheng Cui and Xiaomei Song in Natural Product Communications

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article. This research was financially supported by the Open Research Fund of Key Laboratory of Basic and New Herbal Medicament Research, Shaanxi university of Chinese medicine (No.17JS030); Key R&D Program of Shaanxi Province (grant No.2018SF-324); Subject Innovation Team of Shaanxi University of Chinese Medicine (2019-YL12); Project of science and Technology Department of Shaanxi province (2018ZDXM-SF-007).

ORCID iD

Xiaomei Song

References

Song

XM.

Liu

. Research and Application of "Qi-Medicines" in Taibai Mountains. People's Medical Publishing House. 2011.

Pan

Z-H.

Liu

J-L

et al. A cytotoxic cardenolide and a saponin from the rhizomes of Tupistra chinensis . Fitoterapia. 2012;83(8):1489-1493.doi:10.1016/j.fitote.2012.08.015

http://www.ncbi.nlm.nih.gov/pubmed/22947328

Zou

Wang

. Antitumor test of Tupistra extracts. Chin J Ethnomed Ethnopharm. 2007;86:164-167.

Cai

Zhu

ZG.

Lei

LS.

. Saponin from Tupistra chinensis baker inhibits mouse sarcoma S2180 cell proliferation in vitro and implanted solid tumor growth in mice. J South Med Univ. 2007;27(3):188-194.

Y-Z.

Song

Zheng

X-D

et al. Five new polyhydroxylated furostanol saponins from the rhizomes of Tupistra chinensis . Chin J Nat Med. 2019;17(8):624-630.doi:10.1016/S1875-5364(19)30065-2

http://www.ncbi.nlm.nih.gov/pubmed/31472900

Song

Zhang

et al. Two new spirostanol saponins from the the roots and rhizomes of Tupistra chinensis . Phytochem Lett. 2015;13:6-10.doi:10.1016/j.phytol.2015.05.004

Wang

et al. Steroidal saponins from the roots and rhizomes of Tupistra chinensis . Molecules. 2015;20(8):13659-13669.doi:10.3390/molecules200813659

http://www.ncbi.nlm.nih.gov/pubmed/26225948

Wang

et al. Steroidal Saponins from the Roots and Rhizomes of Tupistra chinensis . Molecules. 2015;20(8):13659-13669.doi:10.3390/molecules200813659

http://www.ncbi.nlm.nih.gov/pubmed/26225948

Liu

Guo

Deng

et al. New furostanol saponins from the rhizomes of Tupistra chinensis . Nat Prod Res. 2013;27(2):123-129.doi:10.1080/14786419.2012.660637

http://www.ncbi.nlm.nih.gov/pubmed/22502647

10.

L-L.

Zou

Wang

J-Z

et al. New polyhydroxylated furostanol saponins with inhibitory action against NO production from Tupistra chinensis rhizomes. Molecules. 2007;12(8):2029-2037.doi:10.3390/12082029

http://www.ncbi.nlm.nih.gov/pubmed/17960103

11.

Cui

Yang

Zhang

et al. Steroidal constituents from roots and rhizomes of Smilacina japonica . Molecules. 2018;23(4):798-804.doi:10.3390/molecules23040798

http://www.ncbi.nlm.nih.gov/pubmed/29601498

12.

Song

Zhang

et al. Two new spirostanol saponins from the the roots and rhizomes of Tupistra chinensis . Phytochem Lett. 2015;13:6-10.doi:10.1016/j.phytol.2015.05.004

13.

Mujumdar

Poulsen

S-A

. Natural product primary sulfonamides and primary sulfamates. J Nat Prod. 2015;78(6):1470-1477.doi:10.1021/np501015m

http://www.ncbi.nlm.nih.gov/pubmed/26035239

14.

Nishimori

Minakuchi

Morimoto

Isao

Tomoko

Kaori

et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem. 2006;49(6):2117-2126.doi:10.1021/jm0512600

http://www.ncbi.nlm.nih.gov/pubmed/16539401

15.

Ceruso

Del Prete

Alothman

Capasso

Supuran

. Sulfonamides with Potent Inhibitory Action and Selectivity against the α-Carbonic Anhydrase from Vibrio cholerae . ACS Med Chem Lett. 2014;5(7):826-830.doi:10.1021/ml500192a

http://www.ncbi.nlm.nih.gov/pubmed/25050173

16.

Potrawa

Michael

. Bluegreen fluorescent compounds. 2011. US 20110190528 A1 20110804.

17.

Beke

Bozo

Farkas

et al. New phenylsulfamoyl benzamide derivatives as bradykinin antagonists. 2008. WO 2008050167 A1 20060127.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

83.38 MB

0.00 MB